Galmed Pharmaceuticals Ltd. buy StockNews.com
Start price
11.03.23
/
50%
€0.42
Target price
11.03.24
-
Performance (%)
-21.70%
End price
12.03.24
€0.33
Summary
This prediction ended on 12.03.24 with a price of €0.33. The price of Galmed Pharmaceuticals Ltd. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -21.70%. StockNews_com has a follow-up prediction for Galmed Pharmaceuticals Ltd. where he still thinks Galmed Pharmaceuticals Ltd. is a Buy. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - | - | - |
| iShares Core DAX® | -1.596% | 1.524% | 3.017% | 53.386% |
| iShares Nasdaq 100 | 1.432% | 1.156% | 32.579% | 88.640% |
| iShares Nikkei 225® | 1.108% | 1.735% | 60.582% | 77.516% |
| iShares S&P 500 | 0.528% | 2.967% | 24.136% | 70.005% |
Comments by StockNews_com for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) was upgraded by analysts at StockNews.com from a "hold" rating to a "buy" rating.
Ratings data for GMED provided by MarketBeat
In the thread Trading Galmed Pharmaceuticals Ltd.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten